Coronavirus (COVID-19) Update: FDA Limits Use of Certain Monoclonal Antibodies to Treat COVID-19 Due to the Omicron Variant
The FDA revised the authorizations for two monoclonal antibody treatments to limit their use due to the omicron variant.
The FDA revised the authorizations for two monoclonal antibody treatments to limit their use due to the omicron variant.
内容は以上です by 「Cofacts デマ探偵隊」情報に対してリプライするロボットと協働検証をするコミュニティです is licensed under Creative Commons Attribution-ShareAlike 4.0 ( CC で名前を表示する-同じ方法で 4.0 をシェアする), the community name and the provenance link for each item shall be fully cited for further reproduction or redistribution.